Global Intravenous Solutions Market Size study & Forecast, by Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition) by Solution Composition (Saline, Carbohydrates, Vitamins and Minerals, Other Solution Compositions) and Regional Analysis, 2022-2029
Global Intravenous Solutions Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Intravenous (IV) solutions are sterile fluids that are administered directly into a patient's bloodstream through a vein. They are commonly used in hospitals, clinics, and other medical settings to provide hydration, medications, nutrients, or other therapeutic agents to patients who are unable to take these substances orally. IV solutions can contain various combinations of water, electrolytes, sugars, vitamins, and medications, depending on the patient's needs. They come in different concentrations and types, such as isotonic, hypotonic, and hypertonic, which determine their effect on the body's fluid balance. The key factor driving the market growth is rise in prevalence of malnutrition, and advancements and new innovations in the products for patient convenience that anticipated to support the market growth during forecast period.
Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.
Major market player included in this report are:
Amanta Healthcare Ltd.
Axa Parenterals Ltd.
B. Braun Melsungen AG
Baxter International Inc.
Dickinson and Company
Eurolife Healthcare Pvt Ltd.
Fresenius Kabi AG
Grifols S.A
Henry Schein Inc.
ICU Medical, Inc.
Recent Developments in the Market:
In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.
Global Intravenous Solutions Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Solution Composition, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Total Parenteral Nutrition
Peripheral Parenteral Nutrition
By Solution Composition:
Saline
Carbohydrates
Vitamins and Minerals
Other Solution Compositions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
Moreover, the prevalence of diseases such gastrointestinal disorders, neurological diseases, and cancer, wherein intravenous solutions are the primary energy sources for patients, is one of the main contributors to the market's growth. With 370,000 deaths in 2019, diarrhea is the second most common cause of death in children under the age of five, according to the World Health Organization. Also, the availability of solutions in portable packages, which makes it simpler for patients to use the drips in the comfort of their homes rather than at a hospital, and product innovations such as premixed solutions for improved convenience and to reduce the amount of packaging waste are a few other factors boosting the market's growth. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion and pharmaceuticals, introduced the user-friendly and infectious disease-reduction intravenous IV devices Discport and Lifeport. Additionally, growing geriatric population is anticipated to create the lucrative opportunity for the market during forecast period. However, lack of experienced healthcare professionals and complications of intravenous administration therapy stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Intravenous Solutions Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and rise in the geriatric population in the region. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising prevalence of chronic diseases, increasing number of collaborations between various stakeholders and rising old age population would create lucrative growth prospects for the Intravenous Solutions market across Asia Pacific region.
Major market player included in this report are:
Amanta Healthcare Ltd.
Axa Parenterals Ltd.
B. Braun Melsungen AG
Baxter International Inc.
Dickinson and Company
Eurolife Healthcare Pvt Ltd.
Fresenius Kabi AG
Grifols S.A
Henry Schein Inc.
ICU Medical, Inc.
Recent Developments in the Market:
In February 2022, B. Braun Medical has been granted approval by the US FDA to begin manufacturing IV saline solutions at its new plant in Daytona Beach, Florida.
Global Intravenous Solutions Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Solution Composition, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Total Parenteral Nutrition
Peripheral Parenteral Nutrition
By Solution Composition:
Saline
Carbohydrates
Vitamins and Minerals
Other Solution Compositions
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INTRAVENOUS SOLUTIONS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET DYNAMICS
3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of malnutrition
3.1.1.2. Advancements and new innovations in the products for patient convenience
3.1.2. Market Challenges
3.1.2.1. Lack of experienced healthcare professionals
3.1.2.2. Complications of intravenous administration therapy
3.1.3. Market Opportunities
3.1.3.1. Growing geriatric population
CHAPTER 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Intravenous Solutions Market, Sub Segment Analysis
6.4.1. Total Parenteral Nutrition
6.4.2. Peripheral Parenteral Nutrition
CHAPTER 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY SOLUTION COMPOSITION
7.1. Market Snapshot
7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
7.4. Intravenous Solutions Market, Sub Segment Analysis
7.4.1. Saline
7.4.2. Carbohydrates
7.4.3. Vitamins and Minerals
7.4.4. Other Solution Compositions
CHAPTER 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET, REGIONAL ANALYSIS
8.1. Intravenous Solutions Market, Regional Market Snapshot
8.2. North America Intravenous Solutions Market
8.2.1. U.S. Intravenous Solutions Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Intravenous Solutions Market
8.3. Europe Intravenous Solutions Market Snapshot
8.3.1. U.K. Intravenous Solutions Market
8.3.2. Germany Intravenous Solutions Market
8.3.3. France Intravenous Solutions Market
8.3.4. Spain Intravenous Solutions Market
8.3.5. Italy Intravenous Solutions Market
8.3.6. Rest of Europe Intravenous Solutions Market
8.4. Asia-Pacific Intravenous Solutions Market Snapshot
8.4.1. China Intravenous Solutions Market
8.4.2. India Intravenous Solutions Market
8.4.3. Japan Intravenous Solutions Market
8.4.4. Australia Intravenous Solutions Market
8.4.5. South Korea Intravenous Solutions Market
8.4.6. Rest of Asia Pacific Intravenous Solutions Market
8.5. Latin America Intravenous Solutions Market Snapshot
8.5.1. Brazil Intravenous Solutions Market
8.5.2. Mexico Intravenous Solutions Market
8.5.3. Rest of Latin America Intravenous Solutions Market
8.6. Rest of The World Intravenous Solutions Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amanta Healthcare Ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Axa Parenterals Ltd.
9.2.3. B. Braun Melsungen AG
9.2.4. Baxter International Inc.
9.2.5. Dickinson and Company
9.2.6. Eurolife Healthcare Pvt Ltd.
9.2.7. Fresenius Kabi AG
9.2.8. Grifols S.A
9.2.9. Henry Schein Inc.
9.2.10. ICU Medical, Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Intravenous Solutions Market, by Region, 2019-2029 (USD Billion)
1.2.2. Intravenous Solutions Market, by Type, 2019-2029 (USD Billion)
1.2.3. Intravenous Solutions Market, by Solution Composition, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL INTRAVENOUS SOLUTIONS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL INTRAVENOUS SOLUTIONS MARKET DYNAMICS
3.1. Intravenous Solutions Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rise in prevalence of malnutrition
3.1.1.2. Advancements and new innovations in the products for patient convenience
3.1.2. Market Challenges
3.1.2.1. Lack of experienced healthcare professionals
3.1.2.2. Complications of intravenous administration therapy
3.1.3. Market Opportunities
3.1.3.1. Growing geriatric population
CHAPTER 4. GLOBAL INTRAVENOUS SOLUTIONS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Intravenous Solutions Market by Type, Performance - Potential Analysis
6.3. Global Intravenous Solutions Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Intravenous Solutions Market, Sub Segment Analysis
6.4.1. Total Parenteral Nutrition
6.4.2. Peripheral Parenteral Nutrition
CHAPTER 7. GLOBAL INTRAVENOUS SOLUTIONS MARKET, BY SOLUTION COMPOSITION
7.1. Market Snapshot
7.2. Global Intravenous Solutions Market by Solution Composition, Performance - Potential Analysis
7.3. Global Intravenous Solutions Market Estimates & Forecasts by Solution Composition 2019-2029 (USD Billion)
7.4. Intravenous Solutions Market, Sub Segment Analysis
7.4.1. Saline
7.4.2. Carbohydrates
7.4.3. Vitamins and Minerals
7.4.4. Other Solution Compositions
CHAPTER 8. GLOBAL INTRAVENOUS SOLUTIONS MARKET, REGIONAL ANALYSIS
8.1. Intravenous Solutions Market, Regional Market Snapshot
8.2. North America Intravenous Solutions Market
8.2.1. U.S. Intravenous Solutions Market
8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. Solution Composition breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Intravenous Solutions Market
8.3. Europe Intravenous Solutions Market Snapshot
8.3.1. U.K. Intravenous Solutions Market
8.3.2. Germany Intravenous Solutions Market
8.3.3. France Intravenous Solutions Market
8.3.4. Spain Intravenous Solutions Market
8.3.5. Italy Intravenous Solutions Market
8.3.6. Rest of Europe Intravenous Solutions Market
8.4. Asia-Pacific Intravenous Solutions Market Snapshot
8.4.1. China Intravenous Solutions Market
8.4.2. India Intravenous Solutions Market
8.4.3. Japan Intravenous Solutions Market
8.4.4. Australia Intravenous Solutions Market
8.4.5. South Korea Intravenous Solutions Market
8.4.6. Rest of Asia Pacific Intravenous Solutions Market
8.5. Latin America Intravenous Solutions Market Snapshot
8.5.1. Brazil Intravenous Solutions Market
8.5.2. Mexico Intravenous Solutions Market
8.5.3. Rest of Latin America Intravenous Solutions Market
8.6. Rest of The World Intravenous Solutions Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Amanta Healthcare Ltd.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Axa Parenterals Ltd.
9.2.3. B. Braun Melsungen AG
9.2.4. Baxter International Inc.
9.2.5. Dickinson and Company
9.2.6. Eurolife Healthcare Pvt Ltd.
9.2.7. Fresenius Kabi AG
9.2.8. Grifols S.A
9.2.9. Henry Schein Inc.
9.2.10. ICU Medical, Inc.
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Intravenous Solutions Market, report scope
TABLE 2. Global Intravenous Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Intravenous Solutions Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Intravenous Solutions Market estimates & forecasts by Solution Composition 2019-2029 (USD Billion)
TABLE 5. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Intravenous Solutions Market
TABLE 70. List of primary sources, used in the study of global Intravenous Solutions Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Intravenous Solutions Market, report scope
TABLE 2. Global Intravenous Solutions Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Intravenous Solutions Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Intravenous Solutions Market estimates & forecasts by Solution Composition 2019-2029 (USD Billion)
TABLE 5. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Intravenous Solutions Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Intravenous Solutions Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Intravenous Solutions Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Intravenous Solutions Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Intravenous Solutions Market
TABLE 70. List of primary sources, used in the study of global Intravenous Solutions Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Intravenous Solutions Market, research methodology
FIG 2. Global Intravenous Solutions Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Intravenous Solutions Market, key trends 2021
FIG 5. Global Intravenous Solutions Market, growth prospects 2022-2029
FIG 6. Global Intravenous Solutions Market, porters 5 force model
FIG 7. Global Intravenous Solutions Market, pest analysis
FIG 8. Global Intravenous Solutions Market, value chain analysis
FIG 9. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Intravenous Solutions Market, regional snapshot 2019 & 2029
FIG 15. North America Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 16. Europe Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 19. Global Intravenous Solutions Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Intravenous Solutions Market, research methodology
FIG 2. Global Intravenous Solutions Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Intravenous Solutions Market, key trends 2021
FIG 5. Global Intravenous Solutions Market, growth prospects 2022-2029
FIG 6. Global Intravenous Solutions Market, porters 5 force model
FIG 7. Global Intravenous Solutions Market, pest analysis
FIG 8. Global Intravenous Solutions Market, value chain analysis
FIG 9. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Intravenous Solutions Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Intravenous Solutions Market, regional snapshot 2019 & 2029
FIG 15. North America Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 16. Europe Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Intravenous Solutions Market 2019 & 2029 (USD Billion)
FIG 19. Global Intravenous Solutions Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
